ESG6 Oct 2026, 03:25 pm
Cohance Lifesciences Gets "Strong" ESG Ratings from Crisil
AI Summary
Cohance Lifesciences Ltd has been voluntarily assigned an ESG Rating of "Crisil ESG 61 (Strong)" and a Core ESG Rating of "Crisil Core ESG 67 (Strong)" by Crisil ESG Ratings & Analytics Limited. The rating was independently determined by Crisil ESG Ratings based on publicly available information and the company did not engage Crisil for this assessment. This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Cohance Lifesciences received "Strong" ESG ratings from Crisil.
- ESG rating is Crisil ESG 61 (Strong).
- Core ESG rating is Crisil Core ESG 67 (Strong).
- Rating was assigned voluntarily by Crisil based on public data.
- Company did not engage Crisil for the ESG rating.
Price Impact
More from COHANCE